1257425

Dilawar Ajani, M.D., P.I. — FEI 3007134943

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
December 16, 2024
Fiscal Year
2025
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Houston, TX (United States)

Additional Details

Clinical Investigator (CI)